Human TruStain FcX™ (Fc Receptor Blocking Solution)

Pricing & Availability
Other Names
Fc Blocker, FcγR blocker, Fc inhibitor
Ave. Rating
Submit a Review
Product Citations
publications
A_Human_TruStain_FcX_031110
Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant rat IgG2b PE mAb (above). Dotted histogram represents unstained cells.
  • C_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (filled histograms) or non-treated (open histograms) THP-1 cells stained with anti-human HLA-DR PE (red) or an isotype control (IgG2a PE, blue) mAbs. Note: non-treated cells show false-negative HLA-DR staining due to high binding of mouse IgG2a isotype.
Cat # Size Price Save
422301 50 tests ¥17,000
422302 200 tests ¥39,000
Description

Human Fc receptors (FcRs) are expressed on a variety of cells, such as monocytes, granulocytes, B cells and dendritic cells. The cells with FcR expression sometimes give false positive or false negative results of immunofluorescent staining due to the FcRs-mediated Ig Fc binding. Human TruStain FcX™ is specially formulated for blocking the FcR-involved unwanted staining without interfering with antibody-mediated specific staining of human cells. Human TruStain FcX™ is compatible with flow cytometric staining with anti-human CD16 (clone 3G8), CD32 (clone FUN-2), and CD64 (clone 10.1) antibodies.

Product Details
Technical data sheet

Product Details

Storage & Handling
Store between 2°C and 8°C.
Application

FC - Quality tested
ICFC, ICC - Reported in the literature, not verified in house

Recommended Usage

It is recommended to add 5 µl of Human TruStain FcX™ per million cells in 100 µl staining volume, mix and incubate at room temperature for 5-10 minutes prior to staining with antibody of interest. It is not necessary to wash cells between these blocking and immunostaining steps.

Application Notes

This buffer contains specialized human IgG in PBS containing 0.09% sodium azide. It is not recommended to be used for staining human IgG. Handle as biohazard agent.

Application References

(PubMed link indicates BioLegend citation)
  1. de la Cruz J, et al. 2011. J. Immunol. 186:2282. PubMed
  2. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  3. Szerlip NJ, et al. 2012. PNAS. 109:3041. PubMed
  4. Bromley SK, et al. 2013. J. Immunol. 190:970. PubMed
  5. Trujilo G, et al. 2013. J. Immunol. 191:848. PubMed
  6. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  7. Euzebio Alves VT, et al. 2013. Infect Immun. 81:4399. PubMed
  8. Borg ZD, et al. 2014. J. Immunol. 192:189. PubMed
  9. Klingenberg R, et al. 2014. Eur Heart J. PubMed
  10. Lines JL, et al. 2014. Cancer Res. 74:1924. PubMed
  11. Decker D, et al. 2014. Lupus. 23:802. PubMed
  12. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  13. Anderson ME Jr, et al. 2014. Otolaryngol Head Neck Surg. 150:880. PubMed
  14. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  15. Shi J, et al. 2014. Blood. 123:4015. PubMed
  16. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  17. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  18. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  19. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  20. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  21. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  22. Vuong TT, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  23. Klingenberg R, et al. 2015. Eur Heart J. 36:1041. PubMed
  24. Wilkinson-Ryan I, et al. 2015. PLoS One.10:125851. PubMed
Product Citations
  1. Yao W, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.04.017. PubMed
  2. Kamada R, et al. 2017. The Journal of Biochemistry. 10.1093/jb/mvx032. PubMed
  3. Deng H, et al. 2017. Arthritis Res Ther. 10.1186/s13075-017-1339-4. PubMed
  4. Metcalf T, et al. 2017. J Immunol. 10.4049/jimmunol.1700148. PubMed
  5. Poon E, et al. 2017. J Immunother Cancer. 10.1186/s40425-017-0268-8. PubMed
  6. Itoh H, et al. 2017. J Vet Med. 10.1155/2017/5701016. PubMed
  7. Lynskey N, et al. 2017. PLoS Pathog.. 10.1371/journal.ppat.1006493. PubMed
  8. Gov L,et al. 2017. J Immunol. 10.4049/jimmunol.1700245. PubMed
  9. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  10. Dashtsoodol N, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01206. PubMed
  11. Eitas T, et al. 2017. PLoS One. 10.1371/journal.pone.0184164. PubMed
  12. Wright AKA, et al. 2017. J Allergy Clin Immunol. 140:1430. PubMed
  13. Wartewig T, et al. 2017. Nature. . 10.1038/nature24649. PubMed
  14. Gao X, et al. 2017. PLoS One. 10.1371/journal.pone.0189167. PubMed
  15. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  16. Kubala MH, et al. 2018. Cell Rep. 25:2177. PubMed
  17. Souriant S, et al. 2019. Cell Rep. 26:3586. PubMed
  18. Yang ZZ, et al. 2019. Cell Rep. 26:2178. PubMed
  19. Raju R, et al. 2017. Stem Cells Dev. 26:274. PubMed
  20. Arrigucci R, et al. 2017. Nat Protoc. 1.364583333. PubMed
  21. Guo JJ, et al. 2017. Exp Ther Med. 3.842361111. PubMed
  22. Riordon DR, et al. 2017. Methods Mol Biol. 1722:127. PubMed
  23. Jiang X, et al. 2018. Cell Mol Immunol. 1.338194444. PubMed
  24. Bricio–Moreno L, et al. 2018. Nat Commun. 2.204861111. PubMed
  25. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  26. Qin XH, et al. 2019. Langmuir. 35:1882. PubMed
  27. Song M, et al. 2018. Nature. 562:423. PubMed
  28. Li Z, et al. 2018. Exp Ther Med. 3.410416667. PubMed
  29. Oetjen KA, et al. 2018. JCI Insight. 3:e124928. PubMed
  30. Chen X, et al. 2019. Exp Ther Med. 1.265972222. PubMed
  31. Franco LM, et al. 2019. J Exp Med. 216:384. PubMed
  32. Fisher RC, et al. 2019. Neoplasia. 1.061805556. PubMed
  33. Cai Q, et al. 2019. Oncol Lett. 2.967361111. PubMed
  34. Starlard–Davenport A, et al. 2019. Br J Haematol. 186:91. PubMed
  35. Zhang W, et al. 2019. Exp Ther Med. 2.490972222. PubMed
  36. Fan C, et al. 2019. Mol Med Rep. 3.002083333. PubMed
  37. Bocharnikov AV, et al. 2019. JCI Insight. 4:e126832. PubMed
  38. Ellyard JI, et al. 2019. Front Immunol. 1.898611111. PubMed
  39. Winkler CW, et al. 2019. J Neuroinflammation. 0.825694444. PubMed
  40. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  41. Feng WW, et al. 2019. Cell Rep. 29:3405. PubMed
  42. Al–Marsoummi S, et al. 2019. Cell Physiol Biochem. 53:999. PubMed
  43. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  44. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  45. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  46. Seamon K, et al. 2020. Front Immunol. 11:396. PubMed
  47. Good Z, et al. 2019. Nat Biotechnol. 37:259. PubMed
  48. Wierzbinska JA, et al. 2020. Genome Med. 12:29. PubMed
  49. Karagiannis TT, et al. 2020. Nat Commun. 2.271527778. PubMed
  50. Mair F, et al. 2020. Cell Rep. 31:107499. PubMed
  51. Sontheimer-Phelps A, et al. 2019. Cell Mol Gastroenterol Hepatol. 9:507. PubMed
  52. Verma SK, et al. 2018. J Biol Chem. 293:254. PubMed
  53. Binnewies M, et al. 2019. Cell. 177:556. PubMed
  54. O'Huallachain M, et al. 2020. Commun Biol. 3:213. PubMed
  55. Stuart T, et al. 2019. Cell. 177:1888. PubMed
  56. Zhu Y, et al. 2019. Cell Stem Cell. 25:542. PubMed
  57. Nobre LV, et al. 2020. eLife. 8:e49894.. PubMed
  58. Xue J, et al. 2020. Arthritis Res Ther. 1.070138889. PubMed
  59. Fuentes I, et al. 2020. Sci Rep. 10:15064. PubMed
  60. Wu X, et al. 2020. Front Immunol. 1.922222222. PubMed
  61. Cruz J, et al. 2011. J Immunol. 186:2282. PubMed
  62. Szerlip N, et al. 2012. Proc Natl Acad Sci U S A. 109:3041. PubMed
  63. Bromley S, et al. 2013. J Immunol. 190:970. PubMed
  64. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  65. Trujillo G, et al. 2013. J Immunol. 191:848. PubMed
  66. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  67. Alves V, et al. 2013. Infect Immun . 81:4399. PubMed
  68. Borg Z, et al. 2014. J Immunol. 192:189. PubMed
  69. Klingenberg R, et al. 2014. Eur Heart J. . PubMed
  70. Lines J, et al. 2014. Cancer Res. 74:1924. PubMed
  71. Decker D, et al. 2014. Lupus. 123:2663. PubMed
  72. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  73. Anderson M, et al. 2014. Otolaryngology Head Neck Surg. 150:880. PubMed
  74. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  75. Shi J, et al. 2014. Blood. 123:4015. PubMed
  76. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  77. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  78. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  79. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  80. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  81. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  82. Vuong T, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  83. Wilkinson-Ryan I, et al. 2015. PLoS One. 10:125851. PubMed
  84. Pleguezuelos O, et al. 2015. Clin Vaccine Immunol. 22: 828 - 835. PubMed
  85. Ali A, et al. 2015. PLoS One. 10: 0131645. PubMed
  86. Wang C, et al. 2015. Clin Immunol. 159: 47-57. PubMed
  87. Alasoo K, et al. 2015. Sci Rep. 5: 12524. PubMed
  88. Pontarini E, et al. 2015. Rheumatology. 54: 1429-1434. PubMed
  89. Galvani S, et al. 2015. Sci Signal. 8: ra79. PubMed
  90. Jama B, Morris G 2014. J Vis Exp. 93: 52257. PubMed
  91. Simon A, et al. 2015. Blood. 126: 378 - 385. PubMed
  92. Lisovsky I, et al. 2015. J Virol. 89: 9909 - 9919. PubMed
  93. Boyerinas B, et al. 2015. Cancer Immunol Res. 3: 1148 - 1157. PubMed
  94. Page K, et al. 2015. J Pharmacol Exp Ther. 355: 199 - 205. PubMed
  95. Jarantow S, et al. 2015. J Biol Chem. 290: 24689 - 24704. PubMed
  96. Beljanski V, et al. 2015. J Virol. 89: 10612 - 10624. PubMed
  97. Lundholm M, et al. 2015. Sci Rep. 5: 15651. PubMed
  98. Zabransky DJ, et al. 2015. Proc Natl Acad Sci U S A. 112: 6205 -6214. PubMed
  99. Seifert L, et al. 2015. Cell Rep. 13: 1909-1921. PubMed
  100. Schneck H, et al. 2015. PLoS One. 10: 0144535. PubMed
  101. Vir P, et al. 2015. PLoS One. 10: 0144904. PubMed
  102. Wanke-Jellinek L, et al. 2016. J Immunol. 196: 767 - 777. PubMed
  103. Surendran N, et al. 2016. Innate Immunity. 22: 63 - 71. PubMed
  104. Shin J, et al. 2016. Sci Rep. 6:23426. PubMed
  105. Lindgren I, et al. 2016. Hum Reprod. 31: 672 - 683. PubMed
  106. Nielsen S, et al. 2016. Nat Cell Biol. 18: 549-560. PubMed
  107. Eichten A, et al. 2016. Cancer Res . 76: 2327-2339. PubMed
  108. Mitton B, et al. 2016. Leukemia. 10.1038/leu.2016.139. PubMed
  109. Jackson S, et al. 2016. J Exp Med. 213: 733 - 750. PubMed
  110. Wolf J, et al. 2016. J Biol Chem. 291: 16186 - 16196. PubMed
  111. Revelo X, et al. 2016. Cell Rep. 16: 717-730. PubMed
  112. Tsuboki J, et al. 2016. Sci Rep. 6:29588. PubMed
  113. Thomas K, et al. 2016. J Leukoc Biol. 100: 177 - 184. PubMed
  114. Gao M, et al. 2016. Sci Rep. 6:29955. PubMed
  115. Nahid M, et al. 2016. J Leukoc Biol. 100: 339 - 349. PubMed
  116. Kanzaki H, et al. 2016. Sci Rep. 6:32259. PubMed
  117. An L, et al. 2016. Sci Rep. 6: 33346. PubMed
  118. Schneeberger V, et al. 2016. PLoS One. 11: 0160587. PubMed
  119. Burel J, et al. 2016. PLoS Pathog. 12: 1005839. PubMed
  120. Maini A, et al. 2016. PLoS One. 11:e0165502. PubMed
  121. Ciarlo E, et al. 2016. Sci Rep. 6:37944. PubMed
  122. Thorek D, et al. 2016. Sci Transl Med. 8: 367ra167. PubMed
  123. Patera A, et al. 2016. J Leukoc Biol. 100(6):1239-1254. PubMed
  124. Burel J, et al. 2016. PLoS Negl Trop Dis. 10:e0005031. PubMed
  125. Goehring K, et al. 2016. J Nutr. 146(12):2559-2566. PubMed
  126. Busch S, et al. 2016. J Immunol. 197(11):4493-4503. PubMed
  127. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  128. Linke M, et al. 2017. Nat Immunol. 18:293-302. PubMed
  129. Wanke F, et al. 2017. Cell Rep. 18(5):1270-1284. PubMed
  130. Bowen J, et al. 2017. PLoS Pathog. 13(2):e1006164. PubMed
  131. Stephanie Elizabeth, Johanna Zandee 2017. Immunol Cell Biol. 10.1038/icb.2017.3. PubMed
  132. Okamura Y, et al. 2017. Allergol Int. 10.1016/j.alit.2017.03.002. PubMed
  133. MacBride M, et al. 2017. Mammalian Genome. 10.1007/s00335-017-9680-0. PubMed
  134. Kirabo A, et al. 2017. J Mol Cell Cardiol. 10.1016/j.yjmcc.2017.03.001. PubMed

Antigen Details

Molecular Family
Fc Receptors
Gene ID
NA

Related FAQs

Is our human Trustain FcX™ (cat# 422302) compatible with anti human CD16, CD32 and CD64 clones 3G8, FUN-2 and 10.1 respectively?

Yes

What is the concentration of Human TruStain FcX™ (Fc receptor blocking solution, Cat#422301)?
This information is proprietary.
Go To Top Version: 4    Revision Date: 07/14/2016

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account